Flugmedizin · Tropenmedizin · Reisemedizin - FTR 2007; 14(2): 93-94
DOI: 10.1055/s-2007-985767
Blickpunkt

© Georg Thieme Verlag KG Stuttgart · New York

Abdominaltyphus auf dem Vormarsch - Wenn die Reise im Krankenhaus endet

Weitere Informationen

Publikationsverlauf

Publikationsdatum:
03. August 2007 (online)

Auch verfügbar auf
 

Touristen, die an Abdominaltyphus erkranken, verbringen durchschnittlich sieben Tage im Krankenhaus. Diese unerwünschte Ferienverlängerung droht Reisenden immer häufiger. Gründe dafür sind vermehrte Reisen nach Südasien und der Vormarsch der dort besonders häufig auftretenden multi-resistenten S. Typhi Bakterien [21], [23]. Heute ist die Mehrzahl dieser Typhuserreger bereits gegen mindestens ein bekanntes Antibiotikum resistent [1], [12], [19]. Impfen tut daher mehr denn je not, denn Abdominaltyphus verläuft ohne wirksame Antibiotikabehandlung in 10-20 % aller Fälle tödlich [4].

Literatur

  • 01 Ackers ML . Puhr ND . Tauxe RV . Mintz ED . Laboratory-based surveillance of Salmonella serotype Typhi infections in the United States: antimicrobial resistance on the rise.  JAMA. 2000;  283 (20) 2668-2673
    Google Scholar
  • 02 Black RE . Levine MM . Ferreccio C . et al . and the Chilean Typhoid Committee  . Efficacy of one or two doses of Ty21a Salmonella typhi vaccine in enteric-coated capsules in a controlled field trial.  Vaccine. 1990;  8 (2) 81-84
    Google Scholar
  • 03 Cancellieri V . Fara GM . Demonstration of specific IgA in human feces after immunization with live Ty21a Salmonella typhi vaccine.  J Infect Dis. 1985;  151 (3) 482-484
    Google Scholar
  • 04 Coburn B . Grassl GA . Finlay BB . Salmonella, the host and disease: a brief review.  Immunol Cell Biol Epub 2006. 2007;  85 (2) 112-118
    Google Scholar
  • 05 Crump JA . Luby SP . Mintz ED . The global burden of typhoid fever.  Bulletin of the World Health Organization. 2004;  82 (5) 346-353
    Google Scholar
  • 06 D'Aoust JY . Pathogenicity of foodborne Salmonella.  Int J Food Microbiol. 1991;  12 17-40
    Google Scholar
  • 07 Ekdahl K . de Jong B . Andersson Y . Risk of Travel-Associated Typhoid and Paratyphoid Fevers in Various Regions.  J Travel Med. 2005;  12 197-204
    Google Scholar
  • 08 Gilman RH . Hornick RB . Woodward WE . et al . Evaluation of a UDP-glucose-4-epimerase-less mutant of Salmonella typhi as a live oral vaccine.  J Infect Dis. 1977;  136 717-723
    Google Scholar
  • 09 Griot-Wenk ME . Hartmann K . Herzog C . et al . Exzellent long-term safety data established in a recent post-marketing surveillance for oral typhoid fever vaccine, Vivotif®.  Italian J Tropical Medicine. 2001;  6 104-105
    Google Scholar
  • 10 House D . Bishop A . Parry C . et al . Typhoid fever: pathogenesis and disease.  Curr Opin Infect Dis. 2001;  14 (5) 573-578
    CrossrefGoogle Scholar
  • 11 Kollaritsch H . Cryz SH Jr . Lang AB . et al . Local and systemic immune responses to combined vibrio cholerae CVD103-HgR and salmonella typhi ty21a live oral vaccines after primary immunization and reimmunization.  Vaccine. 2000;  18 (26) 3031-3039
    CrossrefGoogle Scholar
  • 12 Kumar R . Gupta N . Shalini  . Multidrug-resistant typhoid fever.  Indian J Pediatr. 2007;  74 (1) 39-42
    CrossrefGoogle Scholar
  • 13 Levine MM . Ferreccio C . Abrego P . et al . Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine.  Vaccine. 1999;  17 (suppl 2) S22-S27
    CrossrefGoogle Scholar
  • 14 Levine MM . Ferreccio C . Black RE . Germanier R . Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation.  Lancet. 1987;  1 (8541) 1049-1052
    Google Scholar
  • 15 Levine MM . Ferreccio C . Cryz S . Ortiz E . Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial.  Lancet. 1990;  336 (8720) 891-894
    CrossrefGoogle Scholar
  • 16 Levine MM . Tacket CO . Sztein MB . Host-Salmonella interaction: human trials.  Microbes Infect. 2001;  3 (14-15) 1271-1279
    CrossrefGoogle Scholar
  • 17 Levine MM . Tayler DN . Ferreccio C . Typhoid vaccines come of age.  Pediatr Infect Dis J. 1989;  8 (6) 374-381
    Google Scholar
  • 18 Meltzer E . Sadik C . Schwartz E . Enteric fever in Israeli travelers: a nationwide study.  J Travel Med. 2005;  12 (5) 275-281
    Google Scholar
  • 19 Mirza SH . Beeching NJ . Hart CA . Multidrug resistant typhoid: a global problem.  J Med Microbiol. 1996;  44 (5) 317-319
    Google Scholar
  • 20 Nisini R . Biselli R . Matricardi PM . et al . Clinical and immunological response to typhoid vaccination with parenteral or oral vaccines in two groups of 30 recruits.  Vaccine. 1993;  11 (5) 582-586
    CrossrefGoogle Scholar
  • 21 Parry CM . Typhoid Fever.  Curr Infect Dis Rep. 2004;  6 (1) 27-33
    CrossrefGoogle Scholar
  • 22 Salerno-Goncalves R . Wahid R . Sztein MB . Immunization of volunteers with Salmonella enterica serovar Typhi strain Ty21a elicits the oligoclonal expansion of CD8+ T cells with predominant Vbeta repertoires.  Infect Immun. 2005;  73 (6) 3521-3530
    CrossrefGoogle Scholar
  • 23 Steinberg EB . Bishop R . Haber P . et al . Typhoid fever in travelers: who should be targeted for prevention?.  Clin Infect Dis. 2004;  9 (2) 186-191
    Google Scholar
  • 24 Stubi CL . Landry PR . Pertignat C . et al . Compliance to live oral Ty21a typhoid vaccine, and its effect on viability.  J Travel Med. 2000;  7 (3) 133-137
    Google Scholar
  • 25 Wahdan MH . Serie C . Cerisier Y . et al . A controlled field trial of live Salmonella typhi strain Ty 21a oral vaccine against typhoid: three-year results.  J Infect Dis. 1982;  145 (3) 292-295
    Google Scholar
      >